Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus
Starting soon · Not applicable
Conditions studied: Diabetes, Coronary Artery Disease
In brief
This is a multi-center randomized controlled trial involving patients with 3-vessel coronary artery disease and diabetes mellitus. Enrolled patients will be dividing into real-time heart team decision-making group (intervention group) and usual care group (control group). The intervention group will conduct a real-time online multidisciplinary heart team discussion and decision-making during coronary angiography. The control group will conduct an usual care decision-making.
Key facts
- Study ID
- NCT07326514
- Run by
- China National Center for Cardiovascular Diseases
- People needed
- 1350
- Starts
- 2026-01-01
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2026-01-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Prior PCI or CABG;
- Acute myocardial infarction with ECG and biomarker tests indicating acute phase;
- Concurrent severe valvular heart disease, large vessel disease, or giant ventricular aneurysm requiring surgical intervention;
- Concurrent atrial fibrillation or severe arrhythmia;
- Other emergency admissions where elective revascularization is contraindicated;
- Refusal or rejection of a specific treatment options (PCI or CABG);
- Refusal to participate in the study.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.